Gelsomino F, Boni L, Tiseo M, Ricciardi S, et al. An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy-EDEN trial GOIRC 04-201 Lung Cancer 2024;199:108059.
PMID: 39700681